 |
CytomX Therapeutics
Last updated: January 14, 2024
CEO Sean McCarthy
Country: USA | Funding: $345.4M (+)
Website: http://cytomx.com/
CytomX is unlocking the potential of antibody therapeutics in oncology by developing a novel therapeutic antibody class of highly targeted Probody therapeutics.
Website: http://cytomx.com/
CytomX is unlocking the potential of antibody therapeutics in oncology by developing a novel therapeutic antibody class of highly targeted Probody therapeutics.
